"The U.S. Food and Drug Administration today approved Vimizim (elosulfase alfa), the first FDA-approved treatment for Mucopolysaccharidosis Type IVA (Morquio A syndrome). Morquio A syndrome is a rare, autosomal recessive lysosomal storage disease "...
Menactra Consumer (continued)
Some products that may interact with this drug include: "blood thinners" (such as warfarin), chemotherapy, corticosteroids (such as prednisone, dexamethasone), drugs that weaken the immune system (such as cyclosporine, efalizumab, tacrolimus).
OVERDOSE: If overdose is suspected, contact a poison control center or emergency room immediately. US residents can call their local poison control center at 1-800-222-1222. Canada residents can call a provincial poison control center.
NOTES: As with any vaccine, this vaccine may not fully protect everyone who receives it.
Keep vaccine records for yourself and all of your children, and after your children are grown provide their records to them and their doctors. This will prevent unnecessary re-vaccinations.
MISSED DOSE: It is important that you or your child receive each vaccination as scheduled. Be sure to ask when each dose should be received, and make a note on a calendar to help you remember.
STORAGE: Not applicable. This vaccine is given in a doctor's office and will not be stored at home.
Information last revised September 2013. Copyright(c) 2013 First Databank, Inc.
Additional Menactra Information
Menactra - User Reviews
Menactra User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.